XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target

/PRNewswire/ -- Signet Therapeutics and XtalPi Inc., a physics-based, AI-powered drug R&D company, announced the expansion of their AI drug discovery...

Related Keywords

China ,Shuhao Wen ,Haisheng Zhang ,Ruyu Wang ,Xtalpi Inc ,Dana Farber Harvard Cancer Center ,Harvard Cancer Center ,